In conclusion, we found the unique tumor immune composition resulting from the absence of Ing4 in mammary tumors, consisting of decreased CD4 CTLs indicative of an immune-evasive TME, correlating with increased penetrance (fitness for survival) and metastasis. The gene discussed is ING4; the disease is breast cancer.